Bank of America
SVNT

Bank of America’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Bank of America’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-9,690
Closed -$6K – 8585
2013
Q3 		$6K Buy
9,690
+3,560
+58% +$2.28K ﹤0.01% 7367
2013
Q2 		$3K Buy
+6,130
New +$4.27K ﹤0.01% 7489

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of America's SVNT Position: Q4 2013 in Review

Bank of America sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 9,690 shares — an estimated $6K sold.

Bank of America first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Bank of America reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Bank of America sold 9,690 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $6K.
  • Bank of America first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Bank of America's SAVIENT PHARMACEUTICALS INC position peaked at $6K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Bank of America's 13F filing for Q4 2013, filed 18 Feb 2014.